HDACs/mTOR inhibitor synergizes Cancer Cell International Open Access with pyrotinib in HER2-positive pancreatic cancer through degradation of mutant P53
HDACs/mTOR inhibitor synergizes Cancer Cell International Open Access with pyrotinib in HER2-positive pancreatic cancer through degradation of mutant P53
复制标题
HDACs/mTOR 抑制剂通过降解突变 P53 协同 Cancer Cell International Open Access 与吡咯替尼治疗 HER2 阳性胰腺癌
作者：
Tiebo Mao;Xiaofei Zhang;Haiyan Xu;Xiao Zhang;Weiyu Ge;Shumin Li;Jingyu Ma;Ming Yue;Shengbai Xue;Jiujie Cui;Liwei Wang
